Veterinary Medicines

Dophacyl 1000 mg/g, powder for use in drinking water/milk for cattle and pigs

Authorised
  • Sodium salicylate
Download as PDF

Product identification

Medicine name:
Dophacyl SB 1000 mg/g, powder for use in drinking water/milk for cattle and pigs
Dophacyl 1000 mg/g, powder for use in drinking water/milk for cattle and pigs
Active substance:
  • Sodium salicylate
Target species:
  • Cattle (calf)
  • Pig
Route of administration:
  • In drinking water/milk use

Product details

Active substance and strength:
  • Sodium salicylate
    1000.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water/milk
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Cattle (calf)
      • Meat and offal
        no withdrawal period
    • Pig
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02BA04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Bucket: white polypropylene square container provided with a polypropylene lid. The bucket contains 5 kg of product.
  • Bucket: white polypropylene square container provided with a polypropylene lid. The bucket contains 2.5 kg of product.
  • Bucket: white polypropylene square container provided with a polypropylene lid. The bucket contains 1 kg of product.
  • Securitainer: white cylindrical polypropylene container, covered with a low-density polyethylene lid. The securitainer contains 1 kg of product
  • - Securitainer: white cylindrical polypropylene container, covered with a low-density polyethylene lid. The securitainer contains 500 g of product

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Dopharma Research B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dopharma B.V.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10791/019/001
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0392/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden
Generic of:

Documents

NLV0392001DC_DophacylSB_RMS PuAR_Final.pdf

English (PDF)
Published on: 27/03/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."